Tumour bed boost linked with worse cosmetic outcomes: study

Australian-led research a world-first in patients with non-low-risk DCIS

Two-year results from an ongoing international trial show that women with non-low-risk ductal carcinoma in situ (DCIS) report some poorer cosmetic and functional outcomes when they receive a tumour bed radiotherapy boost.